IL6R and colorectal carcinoma: 2.4. Inhibition Effect of Anti-IL-6R Antibody Treatment (Tocilizumab; ACTEMRA®) on the Tumor Cell Invasiveness of Human CRC SW480 Xenografts Was Superior to the Treated Group of HT-29 Xenografts